These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 31228492

  • 1. Solubilization of Cyclosporine in Topical Ophthalmic Formulations: Preformulation Risk Assessment on a New Solid Form.
    Wu K, Gore A, Graham R, Meller R.
    J Pharm Sci; 2019 Oct; 108(10):3233-3239. PubMed ID: 31228492
    [Abstract] [Full Text] [Related]

  • 2. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C, Bourges JL, Valamanesh F, Trubitsyn G, Torriglia A, Jeanny JC, Behar-Cohen F, Gurny R, Möller M.
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [Abstract] [Full Text] [Related]

  • 3. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.
    Rodriguez-Aller M, Kaufmann B, Guillarme D, Stella C, Furrer P, Rudaz S, El Zaoui I, Valamanesh F, Di Tommaso C, Behar-Cohen F, Veuthey JL, Gurny R.
    Eur J Pharm Biopharm; 2012 Apr; 80(3):544-52. PubMed ID: 22155591
    [Abstract] [Full Text] [Related]

  • 4. A New Hydrate of Cyclosporine: Structural and Physicochemical Characterization.
    Wu K, Gore A, Graham R.
    J Pharm Sci; 2018 Dec; 107(12):3070-3079. PubMed ID: 30114405
    [Abstract] [Full Text] [Related]

  • 5. Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies.
    Yu Y, Chen D, Li Y, Yang W, Tu J, Shen Y.
    Drug Deliv; 2018 Nov; 25(1):888-899. PubMed ID: 29631468
    [Abstract] [Full Text] [Related]

  • 6. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
    Aliabadi HM, Mahmud A, Sharifabadi AD, Lavasanifar A.
    J Control Release; 2005 May 18; 104(2):301-11. PubMed ID: 15907581
    [Abstract] [Full Text] [Related]

  • 7. Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
    Dutescu RM, Panfil C, Merkel OM, Schrage N.
    Eur J Pharm Biopharm; 2014 Sep 18; 88(1):123-8. PubMed ID: 24844949
    [Abstract] [Full Text] [Related]

  • 8. New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.
    Sun F, Zheng Z, Lan J, Li X, Li M, Song K, Wu X.
    Drug Deliv; 2019 Dec 18; 26(1):575-585. PubMed ID: 31172843
    [Abstract] [Full Text] [Related]

  • 9. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN, Mishra SR, Wang L, Abd-Elgawad AH, Soliman OA, El-Dahan MS, Jablonski MM.
    Curr Drug Deliv; 2017 Sep 06; 14(6):875-886. PubMed ID: 27501714
    [Abstract] [Full Text] [Related]

  • 10. Self-assembling colloidal system for the ocular administration of cyclosporine A.
    Luschmann C, Tessmar J, Schoeberl S, Strauß O, Luschmann K, Goepferich A.
    Cornea; 2014 Jan 06; 33(1):77-81. PubMed ID: 24162754
    [Abstract] [Full Text] [Related]

  • 11. Solubilization of cyclosporin A.
    Ran Y, Zhao L, Xu Q, Yalkowsky SH.
    AAPS PharmSciTech; 2001 Jan 18; 2(1):E2. PubMed ID: 14727890
    [Abstract] [Full Text] [Related]

  • 12. A water-soluble prodrug of cyclosporine A for ocular application: a stability study.
    Lallemand F, Perottet P, Felt-Baeyens O, Kloeti W, Philippoz F, Marfurt J, Besseghir K, Gurny R.
    Eur J Pharm Sci; 2005 Sep 18; 26(1):124-9. PubMed ID: 15978789
    [Abstract] [Full Text] [Related]

  • 13. Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions.
    Chennell P, Delaborde L, Wasiak M, Jouannet M, Feschet-Chassot E, Chiambaretta F, Sautou V.
    Eur J Pharm Sci; 2017 Mar 30; 100():230-237. PubMed ID: 28131754
    [Abstract] [Full Text] [Related]

  • 14. Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results.
    Gan L, Gan Y, Zhu C, Zhang X, Zhu J.
    Int J Pharm; 2009 Jan 05; 365(1-2):143-9. PubMed ID: 18773948
    [Abstract] [Full Text] [Related]

  • 15. Rapid determination of drug solubilization versus supersaturation in natural and digested lipids.
    Gautschi N, Bergström CA, Kuentz M.
    Int J Pharm; 2016 Nov 20; 513(1-2):164-174. PubMed ID: 27609663
    [Abstract] [Full Text] [Related]

  • 16. Influence of topical cyclosporine A and dissolvent on corneal epithelium permeability of fluorescein.
    Benítez del Castillo JM, Castillo A, Toledano N, Durán S, del Aguila C, Otero M, García-Sanchez J.
    Doc Ophthalmol; 1995 Nov 20; 91(1):49-55. PubMed ID: 8861636
    [Abstract] [Full Text] [Related]

  • 17. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.
    Aliabadi HM, Brocks DR, Lavasanifar A.
    Biomaterials; 2005 Dec 20; 26(35):7251-9. PubMed ID: 16005061
    [Abstract] [Full Text] [Related]

  • 18. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
    Jóhannsdóttir S, Jansook P, Stefánsson E, Loftsson T.
    Int J Pharm; 2015 Sep 30; 493(1-2):86-95. PubMed ID: 26220650
    [Abstract] [Full Text] [Related]

  • 19. Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery.
    Grimaudo MA, Pescina S, Padula C, Santi P, Concheiro A, Alvarez-Lorenzo C, Nicoli S.
    Mol Pharm; 2018 Feb 05; 15(2):571-584. PubMed ID: 29313693
    [Abstract] [Full Text] [Related]

  • 20. Solubilization and preformulation of poorly water soluble and hydrolysis susceptible N-epoxymethyl-1,8-naphthalimide (ENA) compound.
    Dong Y, Ng WK, Surana U, Tan RB.
    Int J Pharm; 2008 May 22; 356(1-2):130-6. PubMed ID: 18282672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.